Evidence map›Paper›PMID 37329956›Full record

ArticleThe journal of allergy and clinical immunology. In practice2023

Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective.

Aimee Magnarelli, Robert A Wood, Jill Curran, G Caleb Alexander, Jennifer Dantzer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aimee MagnarelliDepartment of Pediatric Allergy, Immunology and Rheumatology, Johns Hopkins School of Medicine, Baltimore, Md.
Robert A WoodDepartment of Pediatric Allergy, Immunology and Rheumatology, Johns Hopkins School of Medicine, Baltimore, Md.
Jill CurranDepartment of Epidemiology, Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.
G Caleb AlexanderDepartment of Epidemiology, Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.
Jennifer DantzerDepartment of Pediatric Allergy, Immunology and Rheumatology, Johns Hopkins School of Medicine, Baltimore, Md. Electronic address: jwrubel1@jhmi.edu.

Funding

RESEARCH TRAINING IN PEDIATRIC ALLERGY &IMMUNOLOGYT32AI007007 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ROBERT A WOOD · 1985 to 2026
$5.4M
Patient-Centered Outcomes of the First Approved Peanut Allergy TreatmentK23AI159143 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Jennifer Anne Dantzer · 2022 to 2026
$994k
NIAID NIH HHS K23 AI159143NIAID NIH HHS T32 AI007007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ArachisPeanut HypersensitivityGenetic VariationHumans

Identifiers

PMID37329956
PMCPMC10592438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.